Shashni, B.; Tran, H.T.; Vong, L.B.; Chung, R.-J.; Nagasaki, Y.
Sorafenib-Loaded Silica-Containing Redox Nanoparticle Decreases Tumorigenic Potential of Lewis Lung Carcinoma. Pharmaceutics 2025, 17, 50.
https://doi.org/10.3390/pharmaceutics17010050
AMA Style
Shashni B, Tran HT, Vong LB, Chung R-J, Nagasaki Y.
Sorafenib-Loaded Silica-Containing Redox Nanoparticle Decreases Tumorigenic Potential of Lewis Lung Carcinoma. Pharmaceutics. 2025; 17(1):50.
https://doi.org/10.3390/pharmaceutics17010050
Chicago/Turabian Style
Shashni, Babita, Hao Thi Tran, Long Binh Vong, Ren-Jei Chung, and Yukio Nagasaki.
2025. "Sorafenib-Loaded Silica-Containing Redox Nanoparticle Decreases Tumorigenic Potential of Lewis Lung Carcinoma" Pharmaceutics 17, no. 1: 50.
https://doi.org/10.3390/pharmaceutics17010050
APA Style
Shashni, B., Tran, H. T., Vong, L. B., Chung, R.-J., & Nagasaki, Y.
(2025). Sorafenib-Loaded Silica-Containing Redox Nanoparticle Decreases Tumorigenic Potential of Lewis Lung Carcinoma. Pharmaceutics, 17(1), 50.
https://doi.org/10.3390/pharmaceutics17010050